References
- Fergusen S, Macdonald RL. Predictors of cerebral infarction in patients with aneurysmal subarachnoid haemorrhage. Neurosurgery 2007;60:658–67; discussion 667.
- Weidauer S, Lanfermann H, Raabe A, Zanella F, Seifert V, Beck J. Impairment of cerebral perfusion and infarct patterns attributable to vasospasm after aneurysmal subarachnoid haemorrhage: a prospective MRI and DSA study. Stroke 2007;38:1831–6.
- Weyer GW, Nolan CP, Macdonald RL. Evidence-based cerebral vasospasm management. Neurosurg Focus 2006;21:E8.
- Kasuya H, Onda H, Takeshita M, Okada Y, Hori T. Efficacy and safety of nicardipine prolonged-release implants for preventing vasospasm in humans. Stroke 2002;33:1011–15.
- Kasuya H, Onda H, Sasahara A, Takeshita M, Hori T. Application of nicardipine prolonged-release implants: analysis of 97 consecutive patients with acute subarachnoid haemorrhage. Neurosurgery 2005;56:895–902; discussion 895–902.
- Krischek B, Kasuya H, Onda H, Hori T. Nicardipine prolonged-release implants for preventing cerebral vasospasm after subarachnoid haemorrhage: effect and outcome in the first 100 patients. Neurol Med Chir (Tokyo) 2007;47:389–94; discussion 394–6.
- Barth M, Capelle HH, Weidauer S, Effect of nicardipine prolonged-release implants on cerebral vasospasm and clinical outcome after severe aneurysmal subarachnoid haemorrhage: a prospective, randomized, double-blind phase IIa study. Stroke 2007;38:330–6.
- Cowan JA Jr, Ziewacz J, Dimick JB, Upchurch GR Jr. Thompson BG use of endovascular coil embolization and surgical clip occlusion for cerebral artery aneurysms. J Neurosurg 2007;107:530–5.
- Tuettenberg J, Czabanka M, Horn P, Clinical evaluation of the safety and efficacy of lumbar cerebrospinal fluid drainage for the treatment of refractory increased intracranial pressure. J Neurosurg 2009;110:1200–8.
- Raabe A, Beck J, Berkefeld J, Recommendations for the management of patients with aneurysmal subarachnoid haemorrhage. Zentralbl Neurochir 2005;66:79–91.
- Macdonald RL, Kassell NF, Mayer S, Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid haemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial. Stroke 2008;39:3015–21.
- Kreiter KT, Mayer SA, Howard G, Sample size estimates for clinical trials of vasospasm in subarachnoid haemorrhage. Stroke 2009;40:2362–7.